Therefore, applying one or two miRNAs cocktail targeting more than two enzymes or arginine transporters, such as targeting CAT-1 and ASS, should be expected more efficient in the treatment of colorectal cancer. The gene discussed is GIT1; the disease is colorectal cancer.